OIDP provides strategic direction and coordination on a number of topics related to infectious disease.
Antibiotic Resistance
The rise of antibiotic-resistant bacteria represents a serious threat to public health and the economy. To support and evaluate the implementation of U.S. government activities, OIDP leads the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB)
- Learn about PACCARB.
Blood and Tissue Safety and Availability
Ensuring that safe blood and tissue products are available is important to the health and well-being of Americans.
- Learn more about HHS blood and tissue safety and availability.
HIV and AIDS
Approximately 1.2 million people in the United States are living with HIV today. OIDP spearheads the federal HIV/AIDS response through a number of activities:
- Learn about Ending the HIV Epidemic in the U.S.
- Learn about the Minority HIV/AIDS Fund.
- Learn about the Presidential Advisory Council on HIV/AIDS.
Preventing Healthcare-Associated Infections
Health care-associated infections, such as bacteria, fungi, viruses, or other less common pathogens, are a significant cause of illness and death. They are often coupled with serious emotional and financial consequences.
- Learn about preventing healthcare-associated infections.
Sexually Transmitted Infections
Rates of sexually transmitted infections have reached all-time highs in recent years. In response to this growing public health epidemic, OIDP launched the first-ever STI Federal Action Plan.
HHS also released new considerations for providers who test patients for syphilis. This resource outlines four main differences between syphilis point-of-care tests and laboratory-based serologic syphilis tests and highlights the best settings to consider use of point-of-care tests. It also examines point-of-care testing program implementation and management, provides answers to common questions, and lists links to related resources.
Congenital syphilis is of specific concern, with CDC reporting nearly 4,000 cases in 2024, a 700% increase in less than 10 years.
- Learn more about STIs.
- Read the STI Federal Action Plan.
- Read Considerations for the Implementation of Point of Care Tests for Syphilis.
Tick-Borne Diseases
Tick-borne diseases are a serious public health problem. OIDP collaborates to advance interagency coordination and research on this topic.
Vaccines and Immunizations
Vaccines are one of the greatest public health achievements.
- Learn about the National Vaccine Program.
- Get information on vaccines and immunizations for you and your loved ones.
- Read the Vaccines National Strategic Plan.
Viral Hepatitis
Viral hepatitis is a serious public health problem that affects millions of Americans each year. To stop the spread of viral hepatitis, OIDP provides strategic OIDP collaborated to develop the Viral Hepatitis National Plan. OIDP also addresses reimbursement in prevention and care services and shares information about hepatitis eliminations efforts.
- Learn more about viral hepatitis.
- Read the Viral Hepatitis National Strategic Plan.